Syra Health Corp (SYRA)

Syra Health Corp. is a healthcare services company listed on OTC Markets as common stock under the symbol SYRA. Based in Carmel, Indiana, the company was incorporated in 2020 and operates in the United States. Its activities span behavioral and mental health, population health, digital health, health education and training, and workforce development and staffing for healthcare providers. Syra Health also develops digital tools such as Syrenity, a mental health application, SyraBot, a care-journey chatbot, and CarePlus, an electronic medical records solution for smaller healthcare organizations. In addition, it provides analytics services, epidemiology and health equity analytics, medical communications, patient education, and healthcare training, and recruits nurses and allied health professionals for fixed-term placements. Its customers include mental health hospitals, government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-SYRA
$0.66
-23.7% Downside
Overvalued
Not available
Not available
Good
0.0%
November 18, 2026
120.7x
6.0x
2.0x
14.912 M
13.804 M
0.9%
39.3%
7.5
83.8%
Valuation • Fair Value

Syra Health Corp (OTC-SYRA) Fair Value by Valuation Model

Review the available estimates for Syra Health Corp (OTC-SYRA), including DCF Fair Value, Ben Graham Formula Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.66

Estimated downside of 23.7% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.70

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0.084

Classic Ben Graham valuation formula reference.

EPV Fair Value

$0.47

Earnings power value estimate.

Comps Fair Value

$0.68

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 6 available valuation references for Syra Health Corp (OTC-SYRA) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Syra Health Corp (OTC-SYRA)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

8.09 M

Current operating scale indicator.

Revenue Forecast

7.226 M

Forward revenue estimate.

EBITDA

87.97 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Syra Health Corp (OTC-SYRA) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Syra Health Corp (OTC-SYRA)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-1.64

Higher caution zone on this screen.

Altman Z-Score

7.5

Relatively strong balance-sheet zone.

FCF / Net Income

83.8%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Syra Health Corp (OTC-SYRA). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Syra Health Corp (OTC-SYRA)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 18, 2026

Days to Earnings

61

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Syra Health Corp (OTC-SYRA), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Syra Health Corp (OTC-SYRA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Syra Health Corp (OTC-SYRA) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Buy

The daily technical read for Syra Health Corp (OTC-SYRA) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Syra Health Corp (OTC-SYRA) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Syra Health Corp (OTC-SYRA) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Syra Health Corp (OTC-SYRA) Stock FAQ

Data-supported answers about Syra Health Corp (OTC-SYRA), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.66
Estimated downside 23.7%
Valuation Rating
Overvalued
Estimated downside of 23.7%
Financial Health
Good
Current financial-health read

The current fair value estimate for Syra Health Corp (OTC-SYRA) is $0.66. This implies an estimated downside of 23.7% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 23.7% versus the current market price.

The current financial health read for Syra Health Corp (OTC-SYRA) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Syra Health Corp (OTC-SYRA) is November 18, 2026.

The latest available data indicates no current dividend yield for Syra Health Corp (OTC-SYRA).

The current P/E ratio listed for Syra Health Corp (OTC-SYRA) is 120.7x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Syra Health Corp is 14.912 M.

The current enterprise value listed for Syra Health Corp is 13.804 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Syra Health Corp is OTC-SYRA, and the stock is listed on OTC Markets.

Syra Health Corp (OTC-SYRA) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Syra Health Corp is 0.9%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Syra Health Corp is 39.3%. Free float helps investors understand how much of the share base is available for public trading.